Equity99
Cheapest Infra Stock ( Biggest Movement Expected ) Univastu india 67 / 70 Test Resistance 120 / 140 Sl 58 Coming Days View Strong View
Ready To Break 75 Soon💲 💲 💲 💲
Please open Telegram to view this post
VIEW IN TELEGRAM
Equity99
Cheapest Infra Stock ( Biggest Movement Expected ) Univastu india 67 / 70 Test Resistance 120 / 140 Sl 58 Coming Days View Strong View
Hot High 75.99🔤 🔤 🔤 🔤 🔤
Please open Telegram to view this post
VIEW IN TELEGRAM
Equity99
Cheapest Infra Stock ( Biggest Movement Expected ) Univastu india 67 / 70 Test Resistance 120 / 140 Sl 58 Coming Days View Strong View
Ready To Bounce back From Lower Levels Towards 80 Next 2 days 🔤 🔤 🔤 🔤
Please open Telegram to view this post
VIEW IN TELEGRAM
Equity99
https://www.moneycontrol.com/news/business/earnings/univastu-india-standalone-september-2025-net-sales-at-rs-46-07-crore-up-65-47-y-o-y-13688175.html
Again ready to break towards 75⚡️⚡️⚡️⚡️⚡️⚡️
Equity99
Trend reversal move on daily chart of UNIVASTU Look at the DAILY chart of UNIVASTU. After down trend stock has formed a trend reversal move on daily chart. MACD also turns bullish. Now above 71 expect rally up to 85/93 levels fast.
Ready To Break soon 100🔤 🔤 🔤
Please open Telegram to view this post
VIEW IN TELEGRAM
Morning Alert..
*NMP 2.0: Railways targets ₹2.5 trillion asset monetisation in five years*
In its largest private-investment drive, the Ministry of Railways will monetise assets worth ₹2.5 trillion over five years as part of the second phase of the national monetisation pipeline (NMP 2.0), Business Standard has learnt. The ₹10 trillion pipeline, which will be the bedrock of central monetisation strategy till 2029-30, announced by Union Finance Minister Nirmala Sitharaman in her Budget speech in February, is in preparatory stages with individual ministries having made initial asset pipelines, and is expected to be unveiled soon. The railways will look to meet this target through public-private partnership (PPP) models and a multi-asset approach, a ministry spokesperson said. In monetisation, the government leverages revenue-generating operational assets by bringing in private participation through PPP, generally on a revenue-sharing basis. “Using this multi-asset approach, the ministry plans to monetise Gati Shakti Cargo Terminals and bring in new freight trains through private funding. Proceeds are expected to be realised through station redevelopment and commercial development around stations in PPP mode, as currently under progress for Vijayawada station,” the spokesperson added.
*Global market action*
Dow Jones – Up by 0.29% or 134.61 points
FTSE – Up by 0.13% or 12.06 points
CAC – Up by 0.02% or 1.58 points
DAX – Down by 0.81% or 186.98 points
Gift Nifty – Up by 0.32% or 83.00 points
*FII/DII activities*
FII – Sold 1766.05Cr worth of shares
DII – Bought 3161.61Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.7x
Nifty Bank – 16.4x
*Stocks with high delivery percentage*
Grindwell Norton Ltd – 93.7%
V-Guard Industries Ltd – 89.4%
Lupin Ltd – 87.5%
Vijaya Diagnostics Centre Ltd – 84.2%
Godrej Consumer Products Ltd – 83.8%
*Commodities updates*
Gold – Rs 124175/10gm, Silver – Rs 154218/kg, Brcrude – Rs 5196/barrel, Copper – Rs 1002.95/kg.
*NMP 2.0: Railways targets ₹2.5 trillion asset monetisation in five years*
In its largest private-investment drive, the Ministry of Railways will monetise assets worth ₹2.5 trillion over five years as part of the second phase of the national monetisation pipeline (NMP 2.0), Business Standard has learnt. The ₹10 trillion pipeline, which will be the bedrock of central monetisation strategy till 2029-30, announced by Union Finance Minister Nirmala Sitharaman in her Budget speech in February, is in preparatory stages with individual ministries having made initial asset pipelines, and is expected to be unveiled soon. The railways will look to meet this target through public-private partnership (PPP) models and a multi-asset approach, a ministry spokesperson said. In monetisation, the government leverages revenue-generating operational assets by bringing in private participation through PPP, generally on a revenue-sharing basis. “Using this multi-asset approach, the ministry plans to monetise Gati Shakti Cargo Terminals and bring in new freight trains through private funding. Proceeds are expected to be realised through station redevelopment and commercial development around stations in PPP mode, as currently under progress for Vijayawada station,” the spokesperson added.
*Global market action*
Dow Jones – Up by 0.29% or 134.61 points
FTSE – Up by 0.13% or 12.06 points
CAC – Up by 0.02% or 1.58 points
DAX – Down by 0.81% or 186.98 points
Gift Nifty – Up by 0.32% or 83.00 points
*FII/DII activities*
FII – Sold 1766.05Cr worth of shares
DII – Bought 3161.61Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.7x
Nifty Bank – 16.4x
*Stocks with high delivery percentage*
Grindwell Norton Ltd – 93.7%
V-Guard Industries Ltd – 89.4%
Lupin Ltd – 87.5%
Vijaya Diagnostics Centre Ltd – 84.2%
Godrej Consumer Products Ltd – 83.8%
*Commodities updates*
Gold – Rs 124175/10gm, Silver – Rs 154218/kg, Brcrude – Rs 5196/barrel, Copper – Rs 1002.95/kg.
Morning Alert..
*India and Canada to reboot trade deal negotiations after 2 years*
After a gap of more than two years amid a tumultuous bilateral relationship, India and Canada have finalised a broad framework and agreed to restart negotiations for a Comprehensive Economic Partnership Agreement (Cepa). Prime Minister Narendra Modi and his Canadian counterpart, Mark Carney, met late on Sunday on the sidelines of the G20 Summit in Johannesburg and agreed to advance relations in trade, investment, technology & innovation, energy, education, defence, and the space sector. “India and Canada have great potential in strengthening trade and investment linkages. We have set a target of $50 billion by 2030 for our bilateral trade. Canadian Pension Funds are also showing keen interest in Indian companies,” Modi posted on X. Speaking at the Indo-Canadian Business Chamber’s annual national convention on Monday in New Delhi, Union Commerce and Industry Minister Piyush Goyal said both countries had finalised the terms of reference and decided to launch and fast-track free-trade agreement negotiations. “The recent meetings that Prime Minister Modi and Prime Minister Mark Carney have had, including the one very recently at the G20 Summit, clearly give a direction for the future of the Canada-India relationship. They have agreed to begin negotiations for a high-ambition comprehensive economic partnership agreement,” the minister said.
*Global market action*
Dow Jones – Down by 0.08% or 37.71 points
FTSE – Down by 0.05% or 4.80 points
CAC – Down by 0.29% or 22.98 points
DAX – Up by 0.63% or 147.31 points
Gift Nifty – Up by 0.11% or 28.50 points
*FII/DII activities*
FII – Sold 4171.75Cr worth of shares
DII – Bought 4512.87Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.6x
Nifty Bank – 16.4x
*Stocks with high delivery percentage*
Indiamart Intermesh Ltd – 91.2%
UBL – 89.9%
Jyothy Labs Ltd – 88.7%
Westlife Foodworld Ltd – 88%
Power Grid oration of India Ltd – 86.6%
*Primary market activities*
IPO opening today
SSMD Agrotech India Ltd (BSE SME) – Issue size 34.09Cr
*Commodities updates*
Gold – Rs 123825/10gm, Silver – Rs 154450/kg, Brcrude – Rs 5232/barrel, Copper – Rs 999.65/kg.
*India and Canada to reboot trade deal negotiations after 2 years*
After a gap of more than two years amid a tumultuous bilateral relationship, India and Canada have finalised a broad framework and agreed to restart negotiations for a Comprehensive Economic Partnership Agreement (Cepa). Prime Minister Narendra Modi and his Canadian counterpart, Mark Carney, met late on Sunday on the sidelines of the G20 Summit in Johannesburg and agreed to advance relations in trade, investment, technology & innovation, energy, education, defence, and the space sector. “India and Canada have great potential in strengthening trade and investment linkages. We have set a target of $50 billion by 2030 for our bilateral trade. Canadian Pension Funds are also showing keen interest in Indian companies,” Modi posted on X. Speaking at the Indo-Canadian Business Chamber’s annual national convention on Monday in New Delhi, Union Commerce and Industry Minister Piyush Goyal said both countries had finalised the terms of reference and decided to launch and fast-track free-trade agreement negotiations. “The recent meetings that Prime Minister Modi and Prime Minister Mark Carney have had, including the one very recently at the G20 Summit, clearly give a direction for the future of the Canada-India relationship. They have agreed to begin negotiations for a high-ambition comprehensive economic partnership agreement,” the minister said.
*Global market action*
Dow Jones – Down by 0.08% or 37.71 points
FTSE – Down by 0.05% or 4.80 points
CAC – Down by 0.29% or 22.98 points
DAX – Up by 0.63% or 147.31 points
Gift Nifty – Up by 0.11% or 28.50 points
*FII/DII activities*
FII – Sold 4171.75Cr worth of shares
DII – Bought 4512.87Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.6x
Nifty Bank – 16.4x
*Stocks with high delivery percentage*
Indiamart Intermesh Ltd – 91.2%
UBL – 89.9%
Jyothy Labs Ltd – 88.7%
Westlife Foodworld Ltd – 88%
Power Grid oration of India Ltd – 86.6%
*Primary market activities*
IPO opening today
SSMD Agrotech India Ltd (BSE SME) – Issue size 34.09Cr
*Commodities updates*
Gold – Rs 123825/10gm, Silver – Rs 154450/kg, Brcrude – Rs 5232/barrel, Copper – Rs 999.65/kg.
Morning Alert..
*Private banks may lose ground again in FY26 as credit growth lags*
India’s private-sector banks are likely to lose market share for a second consecutive year in 2025-26, as their loan books continue to expand much slower than overall bank credit. The combined loan book, or advances, of listed private-sector lenders such as HDFC Bank, ICICI Bank and Axis Bank grew 8.9 per cent year-on-year in FY25 and 9.9 per cent year-on-year in the first half of FY26. This lags behind the 11.4 per cent and 11.7 per cent year-on-year expansion in the combined loan book of all listed banks over the same periods. It could be the first time in more than 15 years that private-sector banks would trail overall bank credit growth for two consecutive years. Private-sector banks’ combined advances rose to ₹77.14 trillion at the end of September 2025, up from ₹73.56 trillion at the close of FY25 and ₹67.53 trillion at FY24-end. By contrast, listed banks’ combined advances rose to ₹193.6 trillion at end-September this year from ₹184.66 trillion at end-March and ₹165.56 trillion at the end of FY24. The analysis is based on the reported annual results and H1FY26 financials of 42 listed banks -- including private-sector banks, public-sector banks and small finance banks -- which together reported advances of ₹193.6 trillion at the end of September. For comparison, overall bank credit reached ₹192.7 trillion as of October 3, 2025.
*Global market action*
Dow Jones – Up by 0.26% or 120.15 points
FTSE – Up by 0.78% or 74.62 points
CAC – Up by 0.82% or 66.13 points
DAX – Up by 0.96% or 225.45 points
Gift Nifty – Up by 0.47% or 123.00 points
*FII/DII activities*
FII – Bought 785.32Cr worth of shares
DII – Bought 3912.47Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.5x
Nifty Bank – 16.4x
*Stocks with high delivery percentage*
Pfizer Ltd – 97.9%
V-Guard Industries Ltd – 93.6%
Grindwell Norton Ltd – 89.5%
Shree Cements Ltd – 81.9%
Dalmia Bharat Ltd – 80.1%
*Primary market activities*
IPOs opening today
K K Silk Mills Ltd (BSE SME) – Issue size 28.50Cr
Mother Nutri Foods Ltd (BSE SME) – Issue size 39.59Cr
Listing today
Excel Soft Technologies Ltd (Main board) – Subscribed 45.46x
Gallard Steel Ltd (BSE SME) – Subscribed 375.54x
*Commodities updates*
Gold – Rs 125324/10gm, Silver – Rs 156442/kg, Brcrude – Rs 5168/barrel, Copper – Rs 1003/kg.
*Private banks may lose ground again in FY26 as credit growth lags*
India’s private-sector banks are likely to lose market share for a second consecutive year in 2025-26, as their loan books continue to expand much slower than overall bank credit. The combined loan book, or advances, of listed private-sector lenders such as HDFC Bank, ICICI Bank and Axis Bank grew 8.9 per cent year-on-year in FY25 and 9.9 per cent year-on-year in the first half of FY26. This lags behind the 11.4 per cent and 11.7 per cent year-on-year expansion in the combined loan book of all listed banks over the same periods. It could be the first time in more than 15 years that private-sector banks would trail overall bank credit growth for two consecutive years. Private-sector banks’ combined advances rose to ₹77.14 trillion at the end of September 2025, up from ₹73.56 trillion at the close of FY25 and ₹67.53 trillion at FY24-end. By contrast, listed banks’ combined advances rose to ₹193.6 trillion at end-September this year from ₹184.66 trillion at end-March and ₹165.56 trillion at the end of FY24. The analysis is based on the reported annual results and H1FY26 financials of 42 listed banks -- including private-sector banks, public-sector banks and small finance banks -- which together reported advances of ₹193.6 trillion at the end of September. For comparison, overall bank credit reached ₹192.7 trillion as of October 3, 2025.
*Global market action*
Dow Jones – Up by 0.26% or 120.15 points
FTSE – Up by 0.78% or 74.62 points
CAC – Up by 0.82% or 66.13 points
DAX – Up by 0.96% or 225.45 points
Gift Nifty – Up by 0.47% or 123.00 points
*FII/DII activities*
FII – Bought 785.32Cr worth of shares
DII – Bought 3912.47Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.5x
Nifty Bank – 16.4x
*Stocks with high delivery percentage*
Pfizer Ltd – 97.9%
V-Guard Industries Ltd – 93.6%
Grindwell Norton Ltd – 89.5%
Shree Cements Ltd – 81.9%
Dalmia Bharat Ltd – 80.1%
*Primary market activities*
IPOs opening today
K K Silk Mills Ltd (BSE SME) – Issue size 28.50Cr
Mother Nutri Foods Ltd (BSE SME) – Issue size 39.59Cr
Listing today
Excel Soft Technologies Ltd (Main board) – Subscribed 45.46x
Gallard Steel Ltd (BSE SME) – Subscribed 375.54x
*Commodities updates*
Gold – Rs 125324/10gm, Silver – Rs 156442/kg, Brcrude – Rs 5168/barrel, Copper – Rs 1003/kg.
Morning Alert..
*Cabinet greenlights ₹7,280 cr scheme for rare earth magnet manufacturing*
The Union Cabinet, in a meeting chaired by Prime Minister Narendra Modi, on Wednesday approved a ₹7,280 crore scheme to promote manufacturing sintered rare-earth permanent magnets (REPM), marking India’s first attempt to build an integrated domestic supply chain for the critical material. The “Scheme to Promote Manufacturing of Sintered Rare Earth Permanent Magnets” aims to create a production capacity of 6,000 tonnes of REPM a year to meet growing demand from sectors such as electric vehicles, renewable energy, electronics, aerospace, and defence, ultimately boosting local manufacturing competitiveness and the broader energy transition. Under the scheme, five beneficiaries will be selected through a global competitive bidding process, with each eligible for up to 1,200 tonnes per annum capacity. It includes ₹6,450 crore in sales-linked incentives for five years and ₹750 crore as capital subsidy for setting up manufacturing facilities. The scheme will run for seven years from the date of the award, including a-two year gestation period for building manufacturing units and five years for incentive disbursement.
*Global market action*
Dow Jones – Up by 0.10% or 48.57 points
FTSE – Up by 0.85% or 82.05 points
CAC – Up by 0.87% or 70.63 points
DAX – Up by 1.10% or 261.59 points
Gift Nifty – Up by 0.19% or 49.50 points
*FII/DII activities*
FII – Bought 4778.03Cr worth of shares
DII – Bought 6247.93Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.8x
Nifty Bank – 16.6x
*Stocks with high delivery percentage*
ZF Commercial vehicles Control System India Ltd – 97.2%
BASF Ltd – 92.8%
Maharashtra Seamless Ltd – 87.1%
GIC of India Ltd – 85.6%
Bharti Airtel Ltd – 85.1%
*Commodities updates*
Gold – Rs 125941/10gm, Silver – Rs 161432/kg, Brcrude – Rs 5193/barrel, Copper – Rs 1008.9/kg.
*Cabinet greenlights ₹7,280 cr scheme for rare earth magnet manufacturing*
The Union Cabinet, in a meeting chaired by Prime Minister Narendra Modi, on Wednesday approved a ₹7,280 crore scheme to promote manufacturing sintered rare-earth permanent magnets (REPM), marking India’s first attempt to build an integrated domestic supply chain for the critical material. The “Scheme to Promote Manufacturing of Sintered Rare Earth Permanent Magnets” aims to create a production capacity of 6,000 tonnes of REPM a year to meet growing demand from sectors such as electric vehicles, renewable energy, electronics, aerospace, and defence, ultimately boosting local manufacturing competitiveness and the broader energy transition. Under the scheme, five beneficiaries will be selected through a global competitive bidding process, with each eligible for up to 1,200 tonnes per annum capacity. It includes ₹6,450 crore in sales-linked incentives for five years and ₹750 crore as capital subsidy for setting up manufacturing facilities. The scheme will run for seven years from the date of the award, including a-two year gestation period for building manufacturing units and five years for incentive disbursement.
*Global market action*
Dow Jones – Up by 0.10% or 48.57 points
FTSE – Up by 0.85% or 82.05 points
CAC – Up by 0.87% or 70.63 points
DAX – Up by 1.10% or 261.59 points
Gift Nifty – Up by 0.19% or 49.50 points
*FII/DII activities*
FII – Bought 4778.03Cr worth of shares
DII – Bought 6247.93Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.8x
Nifty Bank – 16.6x
*Stocks with high delivery percentage*
ZF Commercial vehicles Control System India Ltd – 97.2%
BASF Ltd – 92.8%
Maharashtra Seamless Ltd – 87.1%
GIC of India Ltd – 85.6%
Bharti Airtel Ltd – 85.1%
*Commodities updates*
Gold – Rs 125941/10gm, Silver – Rs 161432/kg, Brcrude – Rs 5193/barrel, Copper – Rs 1008.9/kg.
Special Pharma Stock ( High Conviction)
Rubicon research CMP 650 / 652
Test Resistance 690 / 740 / 790 Sl 595
Coming Days View Strong View
Rubicon research CMP 650 / 652
Test Resistance 690 / 740 / 790 Sl 595
Coming Days View Strong View
Fundamental Research
Rubicon Research is an IP-led specialty pharmaceutical formulations company focused on developing differentiated, patient-centric and affordable products for regulated markets, with a strong presence in the US. Founded in 1999, it has evolved from a development-only outfit into a fully integrated player with its own manufacturing, filings and commercialized products across multiple dosage forms. The company operates R&D and manufacturing facilities in India along with a development centre in Canada and a front-end office in the US, giving it a global innovation and supply footprint. Its capabilities span complex oral, nasal, ophthalmic, topical and drug–device combinations, backed by a sizeable patent estate in drug delivery technologies.
KEY INVESTMENT THESIS
Strong growth and margin trajectory
In Q2 FY26, Rubicon delivered about 39% year-on-year revenue growth with net profit up around 56%, demonstrating operating leverage as the base scales. EBITDA grew faster than sales with margins in the low-20s, reflecting a shift towards specialty/differentiated products and disciplined cost management.
Scaled, differentiated US-focused franchise
Rubicon is among the faster-growing Indian formulation players with an almost complete revenue skew to the US generics and specialty market, giving it exposure to a large, high-value geography. The portfolio is skewed to complex and differentiated products, including drug–device and combination formulations across multiple dosage forms, which supports better pricing power and stickier customer relationships.
Visibility from product and customer diversification
Revenue is well spread, with the top 5 and top 10 products contributing roughly 30% and just over 50% of sales respectively, reducing single-product concentration risk. Stable pricing driven by a focus on specialty products and a rising share of newer launches provides visibility for sustained revenue traction over the next few years.
R&D depth and diversified manufacturing base
Rubicon operates multiple R&D centres in India and Canada, focused on complex generics and life-cycle management, which underpins a steady pipeline of new launches and ANDA filings. Three manufacturing facilities in India with capabilities across oral solids, liquids, nasal and topical dosage forms create diversification and manufacturing flexibility, while regulatory approvals enable supplies to regulated markets.
Rubicon Research is an IP-led specialty pharmaceutical formulations company focused on developing differentiated, patient-centric and affordable products for regulated markets, with a strong presence in the US. Founded in 1999, it has evolved from a development-only outfit into a fully integrated player with its own manufacturing, filings and commercialized products across multiple dosage forms. The company operates R&D and manufacturing facilities in India along with a development centre in Canada and a front-end office in the US, giving it a global innovation and supply footprint. Its capabilities span complex oral, nasal, ophthalmic, topical and drug–device combinations, backed by a sizeable patent estate in drug delivery technologies.
KEY INVESTMENT THESIS
Strong growth and margin trajectory
In Q2 FY26, Rubicon delivered about 39% year-on-year revenue growth with net profit up around 56%, demonstrating operating leverage as the base scales. EBITDA grew faster than sales with margins in the low-20s, reflecting a shift towards specialty/differentiated products and disciplined cost management.
Scaled, differentiated US-focused franchise
Rubicon is among the faster-growing Indian formulation players with an almost complete revenue skew to the US generics and specialty market, giving it exposure to a large, high-value geography. The portfolio is skewed to complex and differentiated products, including drug–device and combination formulations across multiple dosage forms, which supports better pricing power and stickier customer relationships.
Visibility from product and customer diversification
Revenue is well spread, with the top 5 and top 10 products contributing roughly 30% and just over 50% of sales respectively, reducing single-product concentration risk. Stable pricing driven by a focus on specialty products and a rising share of newer launches provides visibility for sustained revenue traction over the next few years.
R&D depth and diversified manufacturing base
Rubicon operates multiple R&D centres in India and Canada, focused on complex generics and life-cycle management, which underpins a steady pipeline of new launches and ANDA filings. Three manufacturing facilities in India with capabilities across oral solids, liquids, nasal and topical dosage forms create diversification and manufacturing flexibility, while regulatory approvals enable supplies to regulated markets.
Morning Alert..
*State capital expenditure at 33.5% of FY26 target, shows CAG data*
States spent 33.5 per cent of their budgeted capital expenditure (capex) during the April–October period of 2025–26 (FY26), an analysis of monthly account reports of 19 states by the Comptroller and Auditor General of India (CAG) showed. Of the 19 states for which data is available, 16 spent less than 50 per cent of their Budget Estimates (BE) for capex in the first seven months of FY26. Haryana led the group by utilising the highest proportion of its BE, spending 85 per cent. Telangana trailed Haryana with 80.1 per cent, while Kerala and Madhya Pradesh spent 52.9 per cent and 47.8 per cent of their BE, respectively. Conversely, four states — Uttar Pradesh (19.4 per cent), Chhattisgarh (17.5 per cent), West Bengal (17.3 per cent), and Tripura (15.1 per cent) — lagged considerably, spending less than 20 per cent of their budgeted capex during the same period. This pace of capital outlays contrasts sharply with the aggregate BE of nearly ₹9.01 trillion for capex across these 19 states, of which actual spending until October has touched around ₹3.01 trillion. According to the latest Controller General of Accounts data, the Centre’s total capex for the first half (April–September) of FY26 stood at 52 per cent of BE.
*Global market action*
Dow Jones – Up by 0.16% or 74.56 points
FTSE – Down by 0.10% or 9.93 points
CAC – Up by 0.05% or 3.77 points
DAX – Up by 0.14% or 33.78 points
Gift Nifty – Up by 0.02% or 6.50 points
*FII/DII activities*
FII – Sold 1255.20Cr worth of shares
DII – Bought 3940.87Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.8x
Nifty Bank – 16.7x
*Stocks with high delivery percentage*
Century Plyboards India Ltd – 91.4%
UBL – 91%
Maharashtra Seamless Ltd – 87.1%
Garware Technical Fibres Ltd – 85.8%
Sun Pharma Industries Ltd – 81.8%
*Primary market activities*
IPOs opening today
Purple Wave Infocom Ltd (BSE SME) – Issue size 31.45Cr
Logiciel Solutions Ltd (BSE SME) – Issue size 39.90Cr
Exato Technologies Ltd (BSE SME) - Issue size 37.45Cr
Listing today
Sudeep Pharma Ltd (Main board) – Subscribed 93.71x
*Commodities updates*
Gold – Rs 125495/10gm, Silver – Rs 162603/kg, Brcrude – Rs 5287/barrel, Copper – Rs 1009.50/kg.
*State capital expenditure at 33.5% of FY26 target, shows CAG data*
States spent 33.5 per cent of their budgeted capital expenditure (capex) during the April–October period of 2025–26 (FY26), an analysis of monthly account reports of 19 states by the Comptroller and Auditor General of India (CAG) showed. Of the 19 states for which data is available, 16 spent less than 50 per cent of their Budget Estimates (BE) for capex in the first seven months of FY26. Haryana led the group by utilising the highest proportion of its BE, spending 85 per cent. Telangana trailed Haryana with 80.1 per cent, while Kerala and Madhya Pradesh spent 52.9 per cent and 47.8 per cent of their BE, respectively. Conversely, four states — Uttar Pradesh (19.4 per cent), Chhattisgarh (17.5 per cent), West Bengal (17.3 per cent), and Tripura (15.1 per cent) — lagged considerably, spending less than 20 per cent of their budgeted capex during the same period. This pace of capital outlays contrasts sharply with the aggregate BE of nearly ₹9.01 trillion for capex across these 19 states, of which actual spending until October has touched around ₹3.01 trillion. According to the latest Controller General of Accounts data, the Centre’s total capex for the first half (April–September) of FY26 stood at 52 per cent of BE.
*Global market action*
Dow Jones – Up by 0.16% or 74.56 points
FTSE – Down by 0.10% or 9.93 points
CAC – Up by 0.05% or 3.77 points
DAX – Up by 0.14% or 33.78 points
Gift Nifty – Up by 0.02% or 6.50 points
*FII/DII activities*
FII – Sold 1255.20Cr worth of shares
DII – Bought 3940.87Cr worth of shares.
*Major Indian Indices PE*
Nifty 50 – 22.8x
Nifty Bank – 16.7x
*Stocks with high delivery percentage*
Century Plyboards India Ltd – 91.4%
UBL – 91%
Maharashtra Seamless Ltd – 87.1%
Garware Technical Fibres Ltd – 85.8%
Sun Pharma Industries Ltd – 81.8%
*Primary market activities*
IPOs opening today
Purple Wave Infocom Ltd (BSE SME) – Issue size 31.45Cr
Logiciel Solutions Ltd (BSE SME) – Issue size 39.90Cr
Exato Technologies Ltd (BSE SME) - Issue size 37.45Cr
Listing today
Sudeep Pharma Ltd (Main board) – Subscribed 93.71x
*Commodities updates*
Gold – Rs 125495/10gm, Silver – Rs 162603/kg, Brcrude – Rs 5287/barrel, Copper – Rs 1009.50/kg.